News Belite Bio, Inc

Equities

BLTE

US07782B1044

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
43.2 ^USD	+5.11%		+13.68%	-5.57%

04-26	Belite Bio Unveils Plan to Offer 651,380 American Depository Shares	MT
03-22	Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting	05-01	GL
Belite Bio Unveils Plan to Offer 651,380 American Depository Shares	04-26	MT
Belite Bio Announces $25 Million Registered Direct Offering	04-25	GL
Belite Bio : Initiates Stargardt Disease Clinical Trial in Japan	04-22	PU
Belite Bio : Announces MHRA Submission of Tinlarebant for Stargardt Disease Clinical Trial in the United Kingdom	04-18	PU
Belite Bio : Submits US IND Amendment to Initiate a Phase 2/3 Clinical Trial of Tinlarebant in Stargardt Disease	03-25	PU
Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan	03-22	MT
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan	03-22	GL
Belite Bio, Inc Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan	03-22	CI
ADRs End Higher, ATRenew Inc. Climbs 26.9%	03-12	DJ
Transcript : Belite Bio, Inc, Q4 2023 Earnings Call, Mar 12, 2024	03-12
Belite Bio's Q4 Loss Narrows	03-12	MT
Belite Bio, Inc Reports Earnings Results for the Full Year Ended December 31, 2023	03-12	CI
Belite Bio, Inc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-12	CI
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website	03-11	GL
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	03-11	GL
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results	03-06	GL
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results	03-06	AQ
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference	03-04	GL
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference	03-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Belite Bio, Inc

Equities

BLTE

US07782B1044

Summary

Filters